PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21868755-0	2011	Celecoxib promotes c-FLIP degradation through Akt-independent inhibition of GSK3.	Celecoxib	0-9	AKT serine/threonine kinase 1	Homo sapiens	46-49	
21868755-5	2011	We found that celecoxib controlled c-FLIP ubiquitination through Akt-independent inhibition of glycogen synthase kinase-3 (GSK3), itself a candidate therapeutic target of interest in colon cancer.	Celecoxib	14-23	AKT serine/threonine kinase 1	Homo sapiens	65-68	
21868755-6	2011	Celecoxib increased the levels of phosphorylated GSK3, including the alpha and beta forms, even in cell lines, where phosphorylated Akt levels were not increased.	Celecoxib	0-9	AKT serine/threonine kinase 1	Homo sapiens	132-135